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The efﬁcacy of cellular signal transduction is of paramount importance for the proper functioning of a cell and an
organism as a whole. Protein kinases are responsible for much of this transmission and thus have been the focal
point of extensive research. While there are numerous commercially available protein kinase assays, the Kinase-
Glo luminescent kinase assay (Promega) provides an easy-to-use and high throughput platform for determining
protein kinase activity. This assay is said to require the use of a microplate spectrophotometer capable of
detecting a luminescent signal. This study shows that:
 The ChemiGenius Bioimaging system (Syngene), typically used for visualizing chemiluminescence from
Western blots, provides an alternative detection system for Kinase-Glo luminescence.
 The novel detection system confers an advantage over traditional luminometers, in that it allows visualization
of the luminescent wells, which allows for the real-time analysis and correction of experimental errors (i.e.
bubble formation).* Corresponding author. Tel.: +1 613 520 2600x7497.
E-mail addresses: ryan.bell42@gmail.com (Ryan A.V. Bell), Kenneth_Storey@carleton.ca (K.B. Storey).
http://dx.doi.org/10.1016/j.mex.2014.07.003
2215-0161/ 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/3.0/).
 Determining kinase kinetics using this detection system produced comparable results to previous studies on
the same enzyme (i.e. glycogen synthase kinase 3).
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/3.0/).
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Kinase-Glo standard curve
ATP standard curves were created using both the Cary Eclipse Fluorescence Spectrophotometer
(Agilent Technologies, ON, Canada) and the ChemiGenius Bioimaging System (Syngene, MD, USA).
Using either machine, Mg-ATP (made in Tris–HCl, pH 7.5) concentrations were varied between
0 and 100mM (as suggested by the Kinase-Glo Plus platform protocol), and made up to a
ﬁnal volume of 50mL in a 96-well Costar opaque black microplate or to a ﬁnal volume of 20mL in a
384-well Costar opaque black microplate. Equal volumes of Kinase-Glo Plus reagent was added to
the wells containing ATP and these solutions were allowed to sit for 10min to allow for the
luminescent signal to stabilize. Detection using the Cary Eclipse spectrophotometer involved
selecting single read mode for a luminescent signal at 550nm (experimentally determined
luminescent lmax) and detecting that signal for 1s. In contrast, utilizing the ChemiGenius
Bioimaging system, no speciﬁc ﬁlter was chosen and luminescence was measured for 1s.
Accompanying GeneTools software was used to measure the luminescence of each well.
Method validation using glycogen synthase kinase assays
Kinetic assays using a skeletal muscle-derived protein kinase, GSK3, were conducted using the
ChemiGenius Bioimaging System. To do so, GSK3was partially puriﬁed from the skeletalmuscle of 13-
lined ground squirrels using ion exchange and afﬁnity chromatography (speciﬁcs of puriﬁcation
procedure given in Appendix A).
Those fractions that contained GSK3 were subsequently pooled and spun in centrifugal ﬁlters
(10kDa cut-off; Amicon) at 8000RPM for 20min at 58C. The resulting concentrate was then used in
GSK3 assays, which contained 50mMATP, 5mMMgCl2, GSK3 peptide (YRRAAVPPSPSLSRHSSPHQ(pS)
EDEEE; SignalChem) ranging from 0 to 185mM, and 25mM Tris–HCl, pH 7.5. The peptide is
phosphorylated at the indicated serine residue as GSK3 will preferentially phosphorylate substrates
that are previously phosphorylated by other kinases. The underlined serine residues in the above
peptide can both be phosphorylated by GSK3 [1]. Selective addition of 1mM LiCl was used to inhibit
GSK3 activity and act as a negative control. Assays were attempted in both 96-well and 384-well
Costar black microplates, and kinase reaction was allowed to proceed for 1h at room temperature
prior to the addition of the Kinase-Glo reagent. Again, once the Kinase-Glo reagent was added, the
reaction wells were allowed to sit for 10min so that the luminescent signal stabilizes. Luminescence
was detected as mentioned above for the ATP standard curve.
GSK3 activity and Km calculation
Luminescent units determined using the GeneTools software were converted to GSK3 activities by
ﬁrst determining the concentration of ATP that remained after the kinase reaction. This is
subsequently converted to the concentration of ATP utilized in the kinase reaction. This valuewas then
divided by the assay time and the amount of protein present in each assay. Protein content of enzyme
preparations was determined with the Bradford assay using the Bio-Rad prepared reagent and bovine
serum albumin as the standard. These activities were then used to determine the Km peptide with the
help of the Kinetics v.3.5.1 computer program [2].
R.A.V. Bell, K.B. Storey /MethodsX 1 (2014) 96–10198Additional information
The Kinase-Glo luminescent kinase assay (Promega) is a high-throughput method for detecting
protein kinase activity by quantifying the amount of ATP remaining following a kinase reaction. The
luminescent signal is produced via the reaction shown below:Protein kinase substrateþ ATP!Phosphorylatedproductþ ADP
Luciferinþ ATPþ half;O2!Oxyluciferinþ AMPþ CO2 þ PPi þ Light[(Fig._1)TD$FIG]
Fig. 1. ATP standard curves for Kinase-Glo Plus luminescent kinase assay platform. (A) The ATP standard curve when utilizing
the Cary Eclipse ﬂuorescent spectrophotometer, and (B) the ATP standard curve when utilizing the ChemiGenius Bioimaging
system. All data were collected using 96-well black microplates. Data are meanSEM, n=3.
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microplate spectrophotometer capable of detecting a luminescent signal (for recent examples see
[3,4]). If not already present within your laboratory, purchase of such a spectrophotometer would be
signiﬁcantly costly. For this reason, alternative detection systems may be extremely useful in
broadening the use of this assay platform, especially if this equipment is common to many labs. The
ChemiGenius Bioimaging system (Syngene) is typically used in detecting ﬂuorescent or chemilumi-
nescent signals from Western blots or electrophoretically separated PCR products (for recent
examples see [5,6]). This study adapts the ChemiGenius Bioimaging system for the Kinase-Glo
platform, validates its use for determining protein kinase activity, and indicates the advantages of
using this Bioimaging system over other luminometers.
Utilization of the ChemiGenius Bioimaging system for the purpose of detecting the luminescent
signal produced by the Kinase-Glo luminescent kinase assay requires that the assay will function as it
would in a traditional luminometer. The ﬁrst step in assessing assay suitability is to determine the
linear dynamic range for the assay using the ChemiGenius Bioimaging system as compared to that
observed with a luminometer. The Kinase-Glo Plus assay platform claims to have a linear dynamic
[(Fig._2)TD$FIG]Fig. 2. Km peptide for GSK3 derived from the skeletal muscle of 13-lined ground squirrels. (A) The kinetic curve for the
determination of Km GSK3 peptide and (B) A representative sequence of luminescent wells that were used to generate kinetic
curves shown in (A). All data were collected using 96-well black microplates. The data representative in graph are meanSEM,
n=3 on independent determinations on separate enzyme samples.
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ﬂuorescence spectrophotometer and the ChemiGenius Bioimaging system (Fig. 1). Both standard
curves elicited R2 values above 0.99. Given the linearity of the Kinase-Glo Plus assay platform, kinetic
analyses were undertaken for GSK3 to determine the suitability of the ChemiGenius Bioimaging
system for kinase assays.
GSK3 was partially isolated from the skeletal muscle of 13-lined ground squirrels using a
combination of ion exchange and afﬁnity chromatography. GSK3 Km peptide was subsequently
determined to be 394mMwhen using the ChemiGenius Bioimaging system for luminescence detection
(Fig. 2). The Km obtained in this study is similar to those determined in studies that utilized other detection
techniques. For instance, a study of wood frog GSK3 found the Km peptide to be 234mMwhen utilizing
radioactive ATP and subsequent detection of radiolabelled peptides on a phosphor screen [7]. In addition
to the seemingly accurate Km curve generated, the ChemiGenius Bioimaging system provided a unique
ability to visualize the end point luminescence after the kinase reaction (Fig. 2B). This advantage over
traditional luminometers allows for well-by-well assessment of experimental error, and for the potential
to correct those errors in real-time. For instance, eliminating small bubbles, that would otherwise be
unseen in luminometers, increases the accuracy and precision of luminescent measurements. It should
also be noted that this type of chemiluminescent detection is not limited to the ChemiGenius Bioimaging
system, but likely many bioimagers that were designed to detect chemiluminescence fromWestern blots
or PCR gels. Individual machine settings will vary, but the novel detection of kinase activity via the Kinase-
Glo platform should be widely applicable.
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Appendix A. Procedural details for the puriﬁcation of GSK3 from the skeletal muscle of 13-lined
ground squirrels
Frozen skeletal muscle tissue from 13-lined ground squirrels was homogenized 1:5 (v:v) in
homogenization buffer (25mM Tris–HCl, pH 8.0, 2.5mM EDTA, 2.5mM EGTA, 15mM b-
mercaptoethanol, 25mM NaF, and 10% glycerol). The resulting homogenate was then spun at 13,
500g for 30min at 58C. The supernatant was then isolated and applied to a DEAE Sephadex column
(6cm1cm, hd) pre-equilibrated in homogenization buffer. This columnwas subsequentlywashed
with 20mL of homogenization buffer to remove any unbound proteins, after which a 0–2M KCl
gradient was used to elute bound proteins.
The location of GSK3 within the DEAE Sephadex fractions was determined by Western blot. SDS
resolving gels (10% (v/v) acrylamide, 400mM Tris, pH 8.8, 0.1% (w/v) SDS, 0.2% (w/v) ammonium
persulfate (APS), 0.04% (v/v) tetramethylethylenediamine (TEMED)) were preparedwith a 5% stacking
gel (5% acrylamide, 190mM Tris, pH 6.8, 0.1% (w/v) SDS, 0.15% (w/v) APS, 0.1% (v/v) TEMED). DEAE
fractions were loaded into these gels and separated electrophoretically in SDS-PAGE running buffer
(25mM Tris-base, 190mM glycine, and 0.1% (w/v) SDS) at 180V for 45min. 3mL of SpectraTM
Multicolor Broad Range Protein Ladder was added to one lane of every gel to act as molecular weight
markers. Following electrophoresis, proteins were electoblotted onto polyvinylidiene diﬂuoride
(PVDF) membranes (Millipore) by wet transfer using transfer buffer (25mM Tris, pH 8.5, 192mM
glycine, and 20% (v/v)methanol). The electroblottingwas run at room temperature for 1.5h at 160mA.
Following protein transfer, the PVDF membranes were incubated overnight at 4 8C with GSK3-a/b
antibody (Santa Cruz Biotechnology) diluted 1:1000 in Tris-buffered saline with Tween-20 (TBST;
20mM Tris-base, 140mM NaCl, 0.05% Tween-20) with a small amount of sodium azide added. After
the overnight incubation, membranes were washed with TBST three times for 5min each, which was
followed by incubation with the anti-mouse secondary antibody conjugated with horseradish
peroxidase (Bioshop Canada) at a dilution of 1:4000 in TBST. Membranes were incubated at room
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then detected using enzymatic chemiluminescence (ECL). To initiate the membrane exposure 600mL
of hydrogen peroxidewasmixedwith 600mL of luminol reagent on themembranes surface for several
seconds. The mixture was then poured off and the chemiluminescence was detected ChemiGenius
Bioimaging System (Syngene, MD, USA). Fractions identiﬁed to have GSK3 within them were then
taken, pooled and held on ice until an afﬁnity column could be constructed.
A blue-agarose column (3cm1cm; hd) was equilibrated in homogenization buffer prior to the
application of the pooledDEAE fractions containingGSK3. This columnwas thenwashedwith 30mL of
homogenization buffer to wash away unbound proteins, and then proteins were eluted with a 0–2M
KCl gradient. Western blots were again used to identify the fractions that contained GSK3.
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